Addressing the Challenges in Downstream Processing Today and Tomorrow - Newer classes of biotherapies will require innovations in processing technology.

Addressing the Challenges in Downstream Processing Today and Tomorrow - Newer classes of biotherapies will require innovations in processing technology. - BioPharm International

home: :

rss feeds/xml

Email Print

Save License

Addressing the Challenges in Downstream Processing Today and Tomorrow

Newer classes of biotherapies will require innovations in processing technology.

Apr 2, 2011
By: Glen R. Bolton, Bernard N. Violand, Richard S. Wright, Shujun Sun, Khurram M. Sunasara, Kathleen Watson, Johnathan L. Coffman, Christopher Gallo, Ranga Godavarti
BioPharm International Supplements
Volume 24, Issue 4, pp. s8-s15

« Previous

1 2 3 456

REFERENCES

1. C. Scott, Bioprocess Intl. 7 (10, Suppl.), (2009).

2. G. Walsh, Eur. J. Pharm. Biopharm. 55 (1), 3–10 (2003).

3. X. Wang et. al., mAbs. 1 (3), 254-267 (2009).

4. G. Jagschies et. al., BioPharm. Int. 19 (June Suppl.), 10–19 (2006).

5. J. R. Birch and A. J. Racher. Adv. Drug Deliv. Rev. 58 (5–6), 671-685 (2006).

6. B.D. Kelley, mAbs 1 (5), 1–10 (2009).

7. B.D. Kelley et.al., Biotechnol. Bioeng, 101 (3), 553–566 (2008).

8. J.L. Coffman, J.F. Kramarczyk, and B.D. Kelley, Biotechnol. Bioeng. 100 (4), 605–618 (2008).

9. B.D. Kelley et. al., Biotechnol. Bioeng. 100 (5), 950–963 (2008).

10. J. Glynn et. al., BioPharm. Int. 22 (October Suppl.), 15-19 (2009).

11. E.J. Suda, et. al., J. Chromatogr. A. 1216 (27), 5256–5264 (2009).

12. B. Kelley, Biotechnol. Prog. 23 (5), 995–1008 (2007).

13. G.R. Bolton, J. Basha, and D.P. LaCasse, Biotechnol. Prog. 26 (6), 1671–1677.

14. C. Winter, US patent 0237762 (2007).

15. G.R. Bolton, H. Araya, and A.W. Boesch, "Membrane Evaporation for Generating Highly Concentrated Protein Therapeutics" International Patent Application WO 2010/111378 A1.

16. M. Shamashkin et. al., Recovery of Biological Products XIV, (Lake Tahoe, CA 2010)

17. A.L. Nelson, E. Dhimolea, and J.M. Reichert, Nat. Rev. Drug. Discov. 9, 767–74 (2010).

18. G. Walsh, Nat. Biotechnol. 29 (9), 917–924 (2010).

19. C. Sheridan, Nat. Biotechnol. 28 (4), 307-310 (2010).

20. G. Walsh, BioPharma. Int. 23 (10), 1–8 (2009).

21. A.L. Nelson and J.M. Reichert, Nat. Biotechnol. 27 (4), 331–337 (2009).

22. M.D. Zolodz et. al., J. Chromatogr. A. 1217 (2), 225–234 (2010).

23. B.N. Violand. "Initial purification of inclusion bodies," in Protein Purification Applications, S. Roe, Ed. (Oxford University Press, Oxford, UK, 2nd ed. 2001), pp. 19–27.

24. J.J. Buckley, S.D. Hoeltzli, and G.V. Johnson, Biotechnol. Appl. Biochem. 56 (1), 27–34 (2010).

25. V. Dechavanne et. al., Protein Expr. Purif. 75 (2), 192–203 (2011).

26. S.C. Alley, N.M. Okeley, and P.D. Senter, Curr. Opin. Chem. Biol. 14 (4), 529–537 (2010).

27. C.F. McDonagh et. al., Protein Eng. Des. Sel. 19 (7), 299–307 (2006).

28. J.R. Junutula et. al., Nat. Biotech. 26 (8), 92–-932 (2009).

« Previous

1 2 3 456